Assessing Clinical Improvement of Infants Hospitalized For Respiratory Syncytial Virus-Related Critical Illness.
-
-
-
-
Available in CDC Stacks on
File Language:
English
Details
-
Alternative Title:The Journal of Infectious Diseases, 2025, v. 232, no. 6: Assessing Clinical Improvement of Infants Hospitalized For Respiratory Syncytial Virus-Related Critical Illness.
-
Journal Article:The Journal of Infectious Diseases
-
Description:Pediatric respiratory syncytial virus (RSV)-related acute lower respiratory tract infection (LRTI) commonly requires hospitalization. The Clinical Progression Scale-Pediatrics (CPS-Ped) measures level of respiratory support and degree of hypoxia across a range of disease severity, but it has not been applied in infants hospitalized with severe RSV-LRTI.
We analyzed data from a prospective surveillance registry of infants hospitalized for RSV-related complications across 39 pediatric intensive care units in the United States from October through December 2022. We assigned CPS-Ped (0 = discharged home at respiratory baseline to 8 = death) at admission and days 2-7, 10, and 14. We identified predictors of clinical improvement (CPS-Ped ≤2 or 3-point decrease) by day 7 using multivariable log-binomial regression models and estimated the sample size (80% power) to detect 15% between-group clinical improvement with CPS-Ped versus hospital length of stay (LOS).
Of 585 hospitalized infants, 138 (23.6%) received invasive mechanical ventilation (IMV) and 1 died. Failure to clinically improve by day 7 occurred in 205 (35%) infants and was associated with age <3 months, prematurity, underlying respiratory condition, and IMV in the first 24 hours in the multivariable analysis. The estimated sample size per arm required for detecting a 15% clinical improvement in a potential study was 584 using CPS-Ped clinical improvement versus 2031 for hospital LOS.
CPS-Ped can be used to capture a range of disease severity and track clinical improvement in infants who develop RSV-related critical illness and could be useful for evaluating therapeutic interventions for RSV. -
Content Notes:Author manuscript
-
Subjects:
- Humans
- Respiratory Syncytial Virus Infections
- Infant
- Male
- Female
- Hospitalization
- Prospective Studies
- Critical Illness
- Intensive Care Units, Pediatric
- Length of Stay
- Respiration, Artificial
- Infant, Newborn
- Respiratory Syncytial Virus, Human
- Severity of Illness Index
- Registries
- Respiratory Tract Infections
-
Keywords:
-
DOI:
-
ISSN:0022-1899 ; 1537-6613
-
Pubmed ID:39812486
-
Pubmed Central ID:PMC12265475
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
Pages in Document:1283-1291 (18 pdf pages)
-
Volume:232
-
Issue:6
-
Collection(s):
-
Main Document Checksum:urn:sha-512:ac4131f3455b67abc6ed570b1bd7c0e8bf1c039702a5d1db7e34f90f5a621c601101a575710ec41938611853f4fd71c4cc4e482ecf230501b4d50e5edd415553
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access